Key result
mHealth interventions show potential for cardiovascular risk factor modification, but current evidence is limited by short follow-up (maximum 6 months) and high drop-out rates.
Answers are grounded in this paper and cite their sources.
mHealth interventions show potential for CVD secondary prevention, but long-term studies addressing patient targeting, health literacy, and data security are needed before widespread clinical integration.
Cardiovascular disease (CVD) has a high prevalence in the population worldwide and represents a huge economic and human burden. There is a strong evidence-based assumption that reducing modifiable CVD risk factors decreases the incidence, morbidity and mortality due to CVD. However, there is low long-term adherence to treatments and recommendations aimed to prevent CVD or to prevent events after CVD has already developed.1 Interventions to promote and enhance patient empowerment are essential components for effective self-care behaviour and risk factor control for chronic diseases and believed to increase adherence to medical treatments and preventive strategies.2 Telemedicine is the utilization of medical information transferred remotely via digital communication to improve or promote the health of patients,3 and is progressively becoming common practice of medicine in many areas of the world. The usual model of care for people with CVD includes regular visits to the doctor and emergency services, involving high healthcare costs. However, new methods to deliver healthcare using mobile digital communication devices, mobile health (mHealth), may increase the number of patients treated while facilitating patient self-management and saving costs. According to the systematic review by Coorey et al.,4 several risk factors and lifestyle habits might be modifiable with the utilization of mobile apps, like high blood pressure, obesity, smoking, dyslipidaemia, and sedentarism, with improvement of medication adherence, quality of life and psychosocial well-being. Although the overall results show encouraging results supporting the idea that mHealth could represent a new paradigm in the delivery of preventive strategies, there are few things that remain unclear. For example, no studies included in the systematic review reported analyses of subgroups based on sex, age or other factors that may help to identify the ideal target population for mHealth interventions. Most of the participants were men, which is different from recent studies where women seem to get a higher benefit when using smartphone-based models.5,6 Identification of a patient’s profile who might potentially benefit the most through the use of mobile applications would be a desirable outcome in future studies addressing the effectiveness of mHealth in cardiovascular disease prevention. The maximum follow-up reported in the studies included in this review was six months, with a high participant drop-out rate in most of the studies. This is a troubling finding considering that secondary prevention is a lifelong intervention, underscoring the need for studies with longer follow-up. Assessing the long-term effectiveness of mHealth interventions proves the value of mHealth in clinical practice. Currently mHealth features may include tracking lifestyle habits, self-monitoring, disease information and other aspects of patient education, all of them with customizable options. Additional research is needed to determine what makes health mobile applications more appealing to users to promote adherence to a healthy lifestyle. In only one study7 of the meta-analysis by Coorey cardiac rehabilitation patients reported that the use of the mHealth intervention allowed themselves to identify personal lifestyle challenges and set future goals. A key question to be answered is whether the health literacy of the participants plays a role in these outcomes. While a recent review states the need for an appropriate health literacy level to guarantee the development of skill self-management by patients,8 no studies targeting secondary prevention of CVD have reported health literacy level as a variable that may affect the outcomes. In order for telemedicine to have a significant impact on healthcare systems, mHealth should offer a sustainable, low-resource and cost-effective approach to a wide range of people, improving patient outcomes, such as reducing hospitalization rates and increasing medication adherence. On the other hand, mobile applications, along with other telemedicine tools, have to be compatible with current clinical care and processes, without increasing time for administrative tasks,9 or requiring a high level of involvement by clinicians in order to improve the chances that mHealth will be incorporated in daily clinical practice. Telemedicine is not just a potential way to transform healthcare by reaching a larger patient population, increasing access to interventions that could otherwise not be accessible by some patients and increasing quality by providing the option of big data analyses focused on healthcare, potentially leading to better outcomes by analysing the variables there recorded. We have come to an era in which telemedicine may be a potential solution and opportunity to improve healthcare services, while maintaining doctor–patient relationships, data confidentiality and security.10 Unfortunately, just one study11 reported mobile application compliance with national confidentiality laws. Healthcare organizations and developers of mHealth programs and applications will have to work together to ensure better data security and confidentiality. Do the patients feel confident when introducing their own information on mobile health applications? According to a recent study,12 80% of the mobile health apps transmit health related data to third-party companies. Because patients have the right to keep their data protected, confidentiality should be assured and the transmission by mobile applications needs to be secured in order to motivate patients to report the most accurate and complete information.13 In summary, further studies are needed to determine whether mobile applications may be useful for long-term CVD management, and whether these interventions may be applied to other CVD populations. A major challenge in cardiac rehabilitation is empowering CVD patients with cost-effective and safe interventions that will improve their long-term prognosis. The results of this systematic review provide a valuable update about the scientific evidence behind the use of telemedicine in the management of patients with CVD in a time when the use of mHealth technology is becoming ubiquitous and when technological advances are outpacing our ability to test and prove their effectiveness. The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. The author(s) received no financial support for the research, authorship, and/or publication of this article.
No takes yet. Share an insight, caveat, or question.
Supervía et al. (2018) conducted an editorial in Cardiovascular disease. mHealth interventions was evaluated. mHealth interventions show potential for cardiovascular risk factor modification, but current evidence is limited by short follow-up (maximum 6 months) and high drop-out rates.
Synapse has enriched 10 related papers. Consider them for comparative context: